| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ACCELERON PHARMA | 2,396,389 | 91,207,000 | 76.05% | ||
| 2 | ALIMERA SCIENCES INC | 3,148,355 | 15,773,000 | 13.15% | ||
| 3 | CERULEAN PHARMA INC | 1,437,441 | 12,951,000 | 10.80% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-006045, filed 2015.05.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
